{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:09:46Z","timestamp":1791230986318,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jbspin.2014.01.008","type":"journal-article","created":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T18:31:07Z","timestamp":1393093867000},"page":"392-397","source":"Crossref","is-referenced-by-count":31,"title":["Serum uric acid and cardiovascular risk: State of the art and perspectives"],"prefix":"10.1016","volume":"81","author":[{"given":"Go\u00ebl","family":"Fenech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Rajzbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika\u00ebl","family":"Mazighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2014.01.008_bib0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(10)60665-4","article-title":"Gout therapeutics: new drugs for an old disease","volume":"377","author":"Burns","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout","volume":"40","author":"Vitart","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.amjmed.2011.11.010","article-title":"Nature versus nurture in gout: a twin study","volume":"125","author":"Krishnan","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0040","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar3199","article-title":"Epidemiology of gout","volume":"12","author":"Roddy","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0050","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar3272","article-title":"Contemporary epidemiology of gout in the UK general population","volume":"13","author":"Cea Soriano","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0055","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/annrheumdis-2011-201254","article-title":"Epidemiology of gout and hyperuricaemia in Italy during the years 2005\u20132009: a nationwide population-based study","volume":"72","author":"Trifiro","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0060","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/1381612811319130011","article-title":"Chronic hyperuricemia, uric acid deposit and cardiovascular risk","volume":"19","author":"Grassi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0065","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.STR.18.6.990","article-title":"Risk factors for extracranial carotid artery atherosclerosis","volume":"18","author":"Crouse","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0021-9150(99)00214-2","article-title":"Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?","volume":"148","author":"Nieto","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0075","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9149(01)01566-1","article-title":"Sex differences in uric acid and risk factors for coronary artery disease","volume":"87","author":"Tuttle","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1047-2797(96)00052-X","article-title":"Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis risk in communities","volume":"6","author":"Iribarren","year":"1996","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0085","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12325-012-0006-z","article-title":"Uric acid is an important predictor for hypertensive early atherosclerosis","volume":"29","author":"Mutluay","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0090","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.HYP.0000072820.07472.3B","article-title":"Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2","volume":"41","author":"Kanellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0095","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells","volume":"16","author":"Kang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","article-title":"Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system","volume":"26","author":"Corry","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0105","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/01.ATV.15.10.1616","article-title":"Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate","volume":"15","author":"Suarna","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0110","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI108880","article-title":"Release of platelet constituents by monosodium urate crystals","volume":"60","author":"Ginsberg","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (2)","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0120","first-page":"59","article-title":"The role of urate and xanthine oxidase inhibitors in cardiovascular disease","volume":"26","author":"George","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0125","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0130","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11926-010-0084-3","article-title":"Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?","volume":"12","author":"Shah","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0145","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.HYP.0000249768.26560.66","article-title":"Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study","volume":"48","author":"Mellen","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-8703(72)90331-6","article-title":"The incidence of hypertension and associated factors: the Israel ischemic heart disease study","volume":"84","author":"Kahn","year":"1972","journal-title":"Am Heart J"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0155","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/oxfordjournals.aje.a115593","article-title":"Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries","volume":"131","author":"Selby","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.HYP.17.6.969","article-title":"Predictors of an increased risk of future hypertension in Utah. A screening analysis","volume":"17","author":"Hunt","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0165","first-page":"677","article-title":"Serum uric acid and hypertension: the Olivetti heart study","volume":"8","author":"Jossa","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0170","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00004872-200107000-00005","article-title":"Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey","volume":"19","author":"Taniguchi","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","article-title":"Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation","volume":"42","author":"Masuo","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1024600905574","article-title":"Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers","volume":"18","author":"Nakanishi","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.HYP.0000150783.79172.bb","article-title":"Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study","volume":"45","author":"Alper","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.HYP.0000150784.92944.9a","article-title":"Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence","volume":"45","author":"Sundstrom","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.0000150785.39055.e8","article-title":"Resurrection of uric acid as a causal risk factor in essential hypertension","volume":"45","author":"Johnson","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0200","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0205","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0210","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1523-1755.2004.00909.x","article-title":"Uric acid and the state of the intrarenal renin-angiotensin system in humans","volume":"66","author":"Perlstein","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0215","first-page":"E1","article-title":"Effect of insulin on uric acid excretion in humans","volume":"268","author":"Quinones Galvan","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0220","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-93-6-817","article-title":"Serum uric acid in essential hypertension: an indicator of renal vascular involvement","volume":"93","author":"Messerli","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0225","doi-asserted-by":"crossref","first-page":"f4262","DOI":"10.1136\/bmj.f4262","article-title":"Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts","volume":"347","author":"Palmer","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0230","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","article-title":"Uric acid and the development of metabolic syndrome in women and men","volume":"57","author":"Sui","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0235","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.23121","article-title":"Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study","volume":"58","author":"Ioachimescu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0240","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/oxfordjournals.aje.a117479","article-title":"Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study","volume":"141","author":"Freedman","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0245","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0250","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/rheumatology\/kes223","article-title":"Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality","volume":"52","author":"Kuo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0260","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0270","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4892(02)00143-1","article-title":"Uric acid and cardiovascular risk","volume":"2","author":"Alderman","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0275","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000186593","article-title":"Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion","volume":"59","author":"Tykarski","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0280","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.HYP.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study","volume":"36","author":"Verdecchia","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.HYP.34.1.144","article-title":"Serum uric acid and cardiovascular events in successfully treated hypertensive patients","volume":"34","author":"Alderman","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0290","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.STR.29.3.635","article-title":"Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus","volume":"29","author":"Lehto","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0295","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/ar3684","article-title":"Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction","volume":"14","author":"Krishnan","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0300","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/hs0402.105927","article-title":"Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke","volume":"33","author":"Chamorro","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0305","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1","article-title":"Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo","volume":"53","author":"Yu","year":"1998","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0310","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.STR.0000081983.34771.D2","article-title":"Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke","volume":"34","author":"Weir","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0315","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","author":"Farrell","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jnnp.74.5.577","article-title":"Long term risks of stroke, myocardial infarction, and vascular death in \u201clow risk\u201d patients with a non-recent transient ischaemic attack","volume":"74","author":"Clark","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0325","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000155990","article-title":"Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke","volume":"26","author":"Koton","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0330","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1523-1755.2004.00484.x","article-title":"The impact of serum uric acid on cardiovascular outcomes in the LIFE study","volume":"65","author":"Hoieggen","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0335","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0340","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0140-6736(99)00260-3","article-title":"Is raised serum uric acid a cause of cardiovascular disease or death?","volume":"354","author":"Dobson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0345","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"Feig","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2014.01.008_bib0350","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/kep069","article-title":"Allopurinol and mortality in hyperuricaemic patients","volume":"48","author":"Luk","year":"2009","journal-title":"Rheumatology (Oxford)"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X14000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:03:25Z","timestamp":1565215405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X14000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1297319X14000104"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2014.01.008","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}